Jonathan P. Foster, Executive Vice President & CFO at Moleculin Biotech, Inc. (MBRX), bought 10,000 shares at $0.86 ($9K) on 2017-04-25, disclosed to the SEC on 2017-04-26.
Open-market purchase of $9k MBRX by Executive Vice President & CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| INFU | BUY | 2015-08-18 | $3K | — | Filing → |
| INFU | BUY | 2015-06-17 | $973 | — | Filing → |
| INFU | BUY | 2015-05-18 | $13K | — | Filing → |